Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Pluvicto × Clear all

NCT06516510 2025-09-25

A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer

Phase EARLY_PHASE1 Terminated

Prostatic Neoplasms